Search Results: Prevention, Detection & Risk + Screening & Early Detection (17 results)
Screening Study for Pancreatic Cancer
https://www.facingourrisk.org/research-clinical-trials/study/330/screening-study-for-pancreatic-cancer
Prevention
Pancreatic cancer screening study for people with BRCA, ATM, or PALB2 genetic mutations
This study will look at how often routine MRI scans detect abnormal findings in people with genetic mutations linked to hereditary cancer, specifically BRCA1, BRCA2, ATM, and PALB2, who are undergoing pancreatic cancer screening. Researchers aim to determine how frequent there are abnormal MRI and endoscopic ultrasound (EUS) results, as well as the occurrence of high-grade pancreatic precancerous lesions and pancreatic cancer. The study will also review the rate of procedures like biopsies and surgeries among participants.
CHANCES: Studying the Connection Between Chemotherapy Exposure and Secondary Cancers of the Blood in Ovarian and other Cancer Survivors
https://www.facingourrisk.org/research-clinical-trials/study/325/chances-studying-the-connection-between-chemotherapy-exposure-and-secondary-cancers-of-the-blood-in-ovarian-cancer-survivors
Prevention
Study focusing on improving outcomes for ovarian and other cancer survivors
The primary goal of the study is to identify risk factors for developing secondary blood cancers and to understand how chemotherapy and PARP inhibitor exposure influence clonal changes in the blood that may predispose to later development of a blood cancer.
Pancreatic Cancer Screening Study (CAPS5)
https://www.facingourrisk.org/research-clinical-trials/study/222/pancreatic-cancer-screening-studycaps5
Prevention
Screening study for people at high risk for pancreatic cancer
CAPS5 is a study looking at screening for early cancer in people with an elevated lifetime risk of developing pancreatic cancer. The goal is to study biomarkers derived from images and tissue samples (blood, pancreas fluid, duodenal fluid) for the early detection of pancreatic cancer and precancerous lesions.
PATROL Study: Prostate Cancer Screening for People AT Genetic Risk FOr Aggressive Disease
https://www.facingourrisk.org/research-clinical-trials/study/291/patrol-study-prostate-cancer-screening-for-people-at-genetic-risk-for-aggressive-disease
Prevention
Screening study for people with a mutation linked to prostate cancer risk
The PATROL (Prostate Cancer Screening for People AT Genetic Risk FOr Aggressive Disease) study is for people at risk for prostate cancer because they carry one or more genes that are known or suspected to increase prostate cancer risk: BRCA2, HOXB13, ATM, BRCA1, MLH1, MSH2, MSH6, PALB2, PMS2, CHEK2, RAD51D, or TP53.
The DETECT Study: Detecting Endometrial Cancer in Tampons
https://www.facingourrisk.org/research-clinical-trials/study/306/the-detect-study-detecting-endometrial-cancer-in-tampons
Prevention
Early detection of endometrial cancer in women over 45 years of age who are undergoing hysterectomy surgery at the University of Alabama
This study will test whether endometrial samples from tampons can be used for early detection of endometrial cancer and is open to women over 45 years of age who are undergoing hysterectomy surgery (surgery to remove the uterus)
Screening Study for Men at High Genetic Risk for Prostate Cancer
https://www.facingourrisk.org/research-clinical-trials/study/72/men-at-high-genetic-risk-for-prostate-cancer
Prevention
Prostate screening with MRI for men with Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) or a BRCA1, BRCA2, HOXB13, ATM, NBN, TP53, BRIP1, CHEK2, PALB2, RAD51C, RAD51D, or other mutation
The National Institutes of Health has a clinical trial for men at high genetic risk for prostate cancer. This is trial is for men without prostate cancer, ages 30 to 75, who have tested positive for Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) or BRCA1, BRCA2, HOXB13, ATM, NBN, TP53, BRIP1, CHEK2, PALB2, RAD51C, RAD51D, or FANC (FANCA, FANCB, FANCC, FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, and FANCM). The trial involves screening MRI of the prostate every two years and biopsy of the prostate if the MRI is abnormal. There is no cost for travel or study-related tests.
Pancreatic Cancer Early Detection for People at High Risk
https://www.facingourrisk.org/research-clinical-trials/study/227/pancreatic-cancer-early-detection-for-people-at-high-risk
Prevention
Registry and biobank for high risk people undergoing pancreatic cancer screening
The study will collect clinical information, family history, and samples (blood, saliva or cheek swab) from people and families at risk for pancreatic cancer. Collecting this information and samples will create a resource to drive research necessary for early detection and prevention of pancreatic ductal adenocarcinoma (PDAC).
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Precancerous Polyps in Lynch Syndrome Patients, CORAL Study
https://www.facingourrisk.org/research-clinical-trials/study/256/early-detection-of-colorectal-cancer-for-people-with-lynch-syndrome
Prevention
People with Lynch Syndrome at risk for colon cancer
This study will colect blood and stool samples to detect colorectal cancer or precancerous polyps in people with Lynch syndrome and those diagnosed with early onset colorectal cancer, diagnosed younger than 50 years old.
The WISDOM Study: Women Informed to Screen Depending on Measures of Risk
https://www.facingourrisk.org/research-clinical-trials/study/45/wisdom-study
Prevention
Study to determine if breast cancer screening can be made better by personalizing each woman’s mammogram schedule
The goal of the Wisdom Study is to determine if breast cancer screening can be made better by personalizing each woman’s mammogram schedule, compared to the current one-size-fits-all, annual approach. The Wisdom Study is designed to end the confusion about when to start and how often to have a mammogram.
MRI Screening in Men at High Risk of Developing Prostate Cancer
https://www.facingourrisk.org/research-clinical-trials/study/260/screening-in-men-at-high-risk-of-developing-prostate-cancer
Prevention
Screening using MRI for men at risk of developing prostate cancer
This study will determine if prostate magnetic resonance imaging (MRI) will find prostate cancer in men at high risk of developing prostate cancer.
Prostate Cancer Genetic Risk Evaluation and Screening Study (PROGRESS)
https://www.facingourrisk.org/research-clinical-trials/study/180/prostate-cancer-genetic-risk-evaluation-and-screening-study-progress
Prevention
People at high risk for prostate cancer due to an inherited mutation
This study will look at how enhanced prostate cancer screening using MRI will improve early detection rates and further understanding of how inherited mutations can lead to development of prostate cancer.
Blood Markers of Early Pancreas Cancer
https://www.facingourrisk.org/research-clinical-trials/study/141/blood-markers-of-early-pancreas-cancer
Prevention
Observational study for people with family history of pancreas cancer or an inherited mutation linked to pancreatic cancer risk
The purpose of this study is to try to find markers of early pancreatic cancer for individuals at higher-than-average risk, expedite the diagnosis in individuals with symptoms, and substantially improve an individual's chance of surviving the disease.
Helping Latinas Understand Their Risk for Breast Cancer and Get Breast Cancer Care
https://www.facingourrisk.org/research-clinical-trials/study/250/helping-latinas-understand-their-risk-for-breast-cancer-and-get-breast-cancer-care
Prevention
Latinas with a high risk of breast cancer
This study will teach Latinas with a high risk of breast cancer about how diet, exercise, ethnicity, genetics and screening and prevention guidelines may impact their likelihood for developing breast cancer. The study will test ways of teaching participants about breast cancer and risk factors, comparing the current standard of care to new personal educational sessions. Bilingual and bicultural staff are available for the phone study to make the study open to both English and Spanish speakers.
Upright MRI for Prostate Cancer Screening
https://www.facingourrisk.org/research-clinical-trials/study/259/upright-mri-for-prostate-cancer-screening
Prevention
Screening for prostate cancer using upright MRI
This study will compare the effectiveness of an upright magnetic resonance imaging (MRI) compared to prostate specific antigen (PSA) and current MRI imaging for prostate cancer screening.
Validating a Blood Test for Early Ovarian Cancer Detection in High-risk Women and Families: MicroRNA Detection Study (MiDE)
https://www.facingourrisk.org/research-clinical-trials/study/138/validating-a-blood-test-for-early-ovarian-cancer-detection-in-high-risk-women-and-families
Prevention
Screening study for women with a BRCA1, BRCA2, BRIP1, PALB2, RAD51C, RAD51D, PMS2, MLH1, MSH2, MSH6, or EPCAM mutation
The goal of MiDe is to develop a clinical diagnostic test to detect early onset ovarian cancer, as currently, there are no good screening or early detection tests available. Participants can be expected to provide up to 4 tubes of blood every 6 months for up to 5 years. We can collect these samples through mobile phlebotomy all around the US. The study is enrolling people with an inherited mutation with a gene linked to ovarian cancer, such as BRCA1, BRCA2, BRIP1, PALB2, RAD51C, RAD51D, PMS2, MLH1, MSH2, MSH6, or EPCAM. Participants can be expected to provide up to 4 tubes of blood every 6 months for up to 5 years. We can collect these samples through mobile phlebotomy all around the US.
A Pancreatic Cancer Screening Study for High Risk Individuals
https://www.facingourrisk.org/research-clinical-trials/study/95/pancreatic-cancer-screening-study-for-high-risk-people
Prevention
Screening study to detect pancreatic cancer and precancer in people with either a strong family history of pancreatic cancer, or an inherited mutation associated with pancreatic cancer risk
The purpose of this study is to screen and detect pancreatic cancer and precancer in people with either a strong family history of pancreatic cancer, or an inherited mutation associated with pancreatic cancer risk.
Magnetic Resonance Imaging (MRI) will be used to screen for early stage pancreatic cancer. Participants will also be asked to donate a blood sample at specific intervals for the creation of a blood bank necessary for the development of a blood-based screening test for pancreatic cancer.
Genomic Services Research Program Study for People with Unexpected Genetic Results
https://www.facingourrisk.org/research-clinical-trials/study/89/study-for-people-with-unexpected-genetic-results
Prevention
This study is recruiting people who received unexpected genetic test results about their cancer risk after having genetic testing done for some other reason
A new study is recruiting people who received unexpected genetic test results about their cancer risk after having genetic testing done for some other reason.
This is a study of people with "secondary results” from genetic testing. Secondary results are unexpected. They are not related to the reason the person had the genetic test but are shared because they may be very important to the person’s health. Most secondary results have to do with high risks for health problems that can be treated or prevented. Many of these results are related to cancer risk. If you think you have received a secondary result, you may be eligible to join this study.
Additional Results on Clinicaltrials.gov Prevention, Detection & Risk + Screening & Early Detection
77 results
Stool Sample Collection Study
NCT ID: NCT06294873 (https://clinicaltrials.gov/study/NCT06294873)
Evaluation of an Online Prostate Cancer Screening Decision Aid
NCT ID: NCT06610474 (https://clinicaltrials.gov/study/NCT06610474)
Impact of Protect Your Colon™ on CRC Screening
NCT ID: NCT05929820 (https://clinicaltrials.gov/study/NCT05929820)
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2
NCT ID: NCT04815876 (https://clinicaltrials.gov/study/NCT04815876)
A Study to Compare the Effectiveness of Two Types of Ultrasound Technologies in Women Who Have Had Breast Cancer
NCT ID: NCT05408260 (https://clinicaltrials.gov/study/NCT05408260)
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
NCT ID: NCT04904757 (https://clinicaltrials.gov/study/NCT04904757)
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
NCT ID: NCT06620627 (https://clinicaltrials.gov/study/NCT06620627)
The Effect of the Prostate Cancer Foundation Screening Guidelines for Black Men on Intention to Screen in Faith-based Communities
NCT ID: NCT06838325 (https://clinicaltrials.gov/study/NCT06838325)
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
NCT ID: NCT06398639 (https://clinicaltrials.gov/study/NCT06398639)
Vaginal Fluid Collection for Detection of Endometrial Cancer
NCT ID: NCT06294886 (https://clinicaltrials.gov/study/NCT06294886)
African Cancer Genome: GMD
NCT ID: NCT05754658 (https://clinicaltrials.gov/study/NCT05754658)
Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy
NCT ID: NCT05678322 (https://clinicaltrials.gov/study/NCT05678322)
Blood Markers of Early Pancreas Cancer
NCT ID: NCT03568630 (https://clinicaltrials.gov/study/NCT03568630)
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
NCT ID: NCT05968157 (https://clinicaltrials.gov/study/NCT05968157)
Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals
NCT ID: NCT06122896 (https://clinicaltrials.gov/study/NCT06122896)
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
NCT ID: NCT00539162 (https://clinicaltrials.gov/study/NCT00539162)
Pancreatic Cancer Detection Consortium
NCT ID: NCT06388967 (https://clinicaltrials.gov/study/NCT06388967)
MRI Screening in Men at High Risk of Developing Prostate Cancer
NCT ID: NCT05608694 (https://clinicaltrials.gov/study/NCT05608694)
Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening
NCT ID: NCT05665660 (https://clinicaltrials.gov/study/NCT05665660)
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
NCT ID: NCT04854304 (https://clinicaltrials.gov/study/NCT04854304)
Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings
NCT ID: NCT05785780 (https://clinicaltrials.gov/study/NCT05785780)
Preliminary Evaluation of Screening for Pancreatic Cancer in Patients with Inherited Genetic Risk
NCT ID: NCT02478892 (https://clinicaltrials.gov/study/NCT02478892)
Shared Decision-making and Colorectal Cancer Screening
NCT ID: NCT04748380 (https://clinicaltrials.gov/study/NCT04748380)
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
NCT ID: NCT06579417 (https://clinicaltrials.gov/study/NCT06579417)
Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity
NCT ID: NCT06542835 (https://clinicaltrials.gov/study/NCT06542835)
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort
NCT ID: NCT05384535 (https://clinicaltrials.gov/study/NCT05384535)
Testing Conversation Aid in Practice
NCT ID: NCT06011434 (https://clinicaltrials.gov/study/NCT06011434)
Reducing Metabolic Dysregulation in Dyads
NCT ID: NCT06117241 (https://clinicaltrials.gov/study/NCT06117241)
The Genomic Medicine at VA Study
NCT ID: NCT04331535 (https://clinicaltrials.gov/study/NCT04331535)
Evaluation of the Bexa Breast Examination
NCT ID: NCT06643767 (https://clinicaltrials.gov/study/NCT06643767)
Early Detection of Advanced Adenomas and Colorectal Cancer
NCT ID: NCT06342440 (https://clinicaltrials.gov/study/NCT06342440)
MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma
NCT ID: NCT03699995 (https://clinicaltrials.gov/study/NCT03699995)
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening
NCT ID: NCT06745895 (https://clinicaltrials.gov/study/NCT06745895)
Upright MRI for Prostate Cancer Screening
NCT ID: NCT03474913 (https://clinicaltrials.gov/study/NCT03474913)
Biennial CEM in Women with a Personal History of Breast Cancer
NCT ID: NCT06105749 (https://clinicaltrials.gov/study/NCT06105749)
Promoting Informed Choice for Breast Cancer Screening: a Longitudinal Study
NCT ID: NCT05838417 (https://clinicaltrials.gov/study/NCT05838417)
Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
NCT ID: NCT05056818 (https://clinicaltrials.gov/study/NCT05056818)
Community Services Navigation to Advance Health Equity in Breast Cancer Screening
NCT ID: NCT06305312 (https://clinicaltrials.gov/study/NCT06305312)
DermaSensor Postmarket Surveillance Study
NCT ID: NCT06666790 (https://clinicaltrials.gov/study/NCT06666790)
Empowering Latinas to Obtain Guideline Concordant Screenings
NCT ID: NCT05841355 (https://clinicaltrials.gov/study/NCT05841355)
Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
NCT ID: NCT05732623 (https://clinicaltrials.gov/study/NCT05732623)
Interventional Program Educates, Identifies + Overcomes Barriers to Complete Screening Mammography
NCT ID: NCT04348123 (https://clinicaltrials.gov/study/NCT04348123)
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
NCT ID: NCT06151223 (https://clinicaltrials.gov/study/NCT06151223)
Evaluation of Gixam's Performance in a FIT Negative Population
NCT ID: NCT06612281 (https://clinicaltrials.gov/study/NCT06612281)
Magnetic Resonance Imaging of Breast Cancer
NCT ID: NCT01035112 (https://clinicaltrials.gov/study/NCT01035112)
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
NCT ID: NCT04877912 (https://clinicaltrials.gov/study/NCT04877912)
Pilot Study for Colorectal Cancer and Advanced Adenoma Detection with the Mainz Biomed Colorectal Cancer Test
NCT ID: NCT06864338 (https://clinicaltrials.gov/study/NCT06864338)
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT ID: NCT00843375 (https://clinicaltrials.gov/study/NCT00843375)
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NCT ID: NCT05625659 (https://clinicaltrials.gov/study/NCT05625659)
A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men
NCT ID: NCT06052202 (https://clinicaltrials.gov/study/NCT06052202)
Collection of Samples USOPTIVAL Study
NCT ID: NCT04792684 (https://clinicaltrials.gov/study/NCT04792684)
Predicting Chronic Pain Following Breast Surgery
NCT ID: NCT04967352 (https://clinicaltrials.gov/study/NCT04967352)
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
NCT ID: NCT03729115 (https://clinicaltrials.gov/study/NCT03729115)
Comparison of Contrast Agents in Liver MR for the Detection of Hepatic Metastases
NCT ID: NCT04973007 (https://clinicaltrials.gov/study/NCT04973007)
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients, CORAL Study
NCT ID: NCT05410977 (https://clinicaltrials.gov/study/NCT05410977)
Prostate Cancer Genetic Risk Evaluation and Screening Study
NCT ID: NCT05129605 (https://clinicaltrials.gov/study/NCT05129605)
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
NCT ID: NCT05612347 (https://clinicaltrials.gov/study/NCT05612347)
Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer
NCT ID: NCT04473833 (https://clinicaltrials.gov/study/NCT04473833)
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
NCT ID: NCT04825834 (https://clinicaltrials.gov/study/NCT04825834)
The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts
NCT ID: NCT05667532 (https://clinicaltrials.gov/study/NCT05667532)
A Prospective, Multi-center, Observational Study for Signal-C Test Evaluation
NCT ID: NCT06059963 (https://clinicaltrials.gov/study/NCT06059963)
Cone Beam Breast CT for Breast Cancer Screening
NCT ID: NCT05036096 (https://clinicaltrials.gov/study/NCT05036096)
The Effect of IBD Flares on Serum PSA
NCT ID: NCT03558048 (https://clinicaltrials.gov/study/NCT03558048)
Understanding Patient Preference on Colorectal Cancer Screening Options-PSU
NCT ID: NCT06444542 (https://clinicaltrials.gov/study/NCT06444542)
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
NCT ID: NCT05694559 (https://clinicaltrials.gov/study/NCT05694559)
Breast Cancer AI Imaging Study
NCT ID: NCT06604078 (https://clinicaltrials.gov/study/NCT06604078)
Project 1: Self-Triage by 2D Full-field Digital Mammography or Synthetic Images
NCT ID: NCT05960188 (https://clinicaltrials.gov/study/NCT05960188)
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals
NCT ID: NCT03250078 (https://clinicaltrials.gov/study/NCT03250078)
Endometrial Cell Collection With the PadKit
NCT ID: NCT06464107 (https://clinicaltrials.gov/study/NCT06464107)
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
NCT ID: NCT04030507 (https://clinicaltrials.gov/study/NCT04030507)
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
NCT ID: NCT06760507 (https://clinicaltrials.gov/study/NCT06760507)
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
NCT ID: NCT05483283 (https://clinicaltrials.gov/study/NCT05483283)
Early Detection of Breast Cancer
NCT ID: NCT06043661 (https://clinicaltrials.gov/study/NCT06043661)
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
NCT ID: NCT05524428 (https://clinicaltrials.gov/study/NCT05524428)
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
NCT ID: NCT06336928 (https://clinicaltrials.gov/study/NCT06336928)
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
NCT ID: NCT05298605 (https://clinicaltrials.gov/study/NCT05298605)
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
NCT ID: NCT03937453 (https://clinicaltrials.gov/study/NCT03937453)
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.